No connection

Search Results

BABA vs LEGH

BABA
Alibaba Group Holding Limited
NEUTRAL
Price
$173.23
Market Cap
$413.56B
Sector
Consumer Cyclical
AI Confidence
65%
LEGH
Legacy Housing Corporation
BEARISH
Price
$21.10
Market Cap
$502.4M
Sector
Consumer Cyclical
AI Confidence
85%

Valuation

P/E Ratio
BABA
23.6
LEGH
12.13
Forward P/E
BABA
19.5
LEGH
9.95
P/B Ratio
BABA
2.71
LEGH
0.95
P/S Ratio
BABA
0.41
LEGH
3.05
EV/EBITDA
BABA
20.1
LEGH
9.88

Profitability

Gross Margin
BABA
41.17%
LEGH
47.41%
Operating Margin
BABA
2.17%
LEGH
26.89%
Profit Margin
BABA
12.19%
LEGH
25.41%
ROE
BABA
11.19%
LEGH
8.18%
ROA
BABA
4.03%
LEGH
5.43%

Growth

Revenue Growth
BABA
4.8%
LEGH
-29.4%
Earnings Growth
BABA
-51.8%
LEGH
-41.8%

Financial Health

Debt/Equity
BABA
0.27
LEGH
0.0
Current Ratio
BABA
1.46
LEGH
3.51
Quick Ratio
BABA
0.84
LEGH
1.19

Dividends

Dividend Yield
BABA
0.59%
LEGH
--
Payout Ratio
BABA
14.4%
LEGH
0.0%

AI Verdict

BABA NEUTRAL

The Advanced Deterministic Scorecard reveals a mixed financial profile for Alibaba (BABA), with a weak Piotroski F-Score of 4/9 indicating suboptimal financial health, and no available Altman Z-Score limiting distress risk assessment. While valuation metrics appear favorable relative to peers—especially a Price/Sales of 0.41 and Forward P/E of 19.50—earnings growth is sharply negative (YoY EPS down 71%), and recent quarterly beats have reversed into consistent misses over the last four quarters. Strong insider sentiment and a bullish analyst consensus (strong_buy) contrast with deteriorating profitability and weak technical trends (10/100). The stock trades significantly above the Graham Number ($102.68) and intrinsic value estimate ($51.38), suggesting overvaluation unless growth rebounds materially.

Strengths
Attractive valuation multiples relative to sector: P/E (23.60) and Price/Sales (0.41) well below sector averages (Avg P/E: 49.05, Avg P/S: N/A but implied high)
Low debt burden with Debt/Equity of 0.27, well below sector average of 1.63, providing financial flexibility
Strong gross margin of 41.17%, reflecting pricing power and operational efficiency in core e-commerce
Risks
Weak Piotroski F-Score of 4/9 signals deteriorating financial health—penalizes health score per instructions
Earnings in freefall: YoY EPS growth down 71.0%, Q/Q down 70.4%, with last four quarters missing estimates by an average of -10.5%
Operating margin collapsed to 2.17%, indicating severe pressure in profitability despite stable gross margins
LEGH BEARISH

LEGH presents a classic 'value trap' scenario, characterized by a weak Piotroski F-Score of 3/9 and severe fundamental deterioration. While the company maintains an exceptionally clean balance sheet with zero debt and high profit margins, these are overshadowed by a collapse in growth, with revenue and earnings plummeting by approximately 30% and 42% respectively. The stock trades below its Graham Number ($29.48) but significantly above its growth-based intrinsic value ($12.18), suggesting that current valuation metrics are lagging behind the rapid decline in operational performance.

Strengths
Zero Debt/Equity ratio indicating no leverage risk
Strong liquidity with a Current Ratio of 3.51
High profitability margins (Gross 47.41%, Profit 25.41%)
Risks
Severe revenue contraction (-29.40% YoY)
Significant earnings decline (-41.80% YoY)
Consistent failure to meet earnings estimates (1/4 beats in last year)

Compare Another Pair

BABA vs LEGH: Head-to-Head Comparison

This page compares Alibaba Group Holding Limited (BABA) and Legacy Housing Corporation (LEGH) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.

Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.

Home
Terminal
AI
Markets
Profile